The emerging roles of aberrant alternative splicing in glioma
Open Access
- 6 February 2025
- journal article
- review article
- Published by Springer Nature in Cell Death Discovery
- Vol. 11 (1) , 1-11
Abstract
Gliomas represent a heterogeneous group of uniformly fatal brain tumors. Low and high-grade gliomas have diverse molecular signatures. Despite successful advances in understanding glioma, several genetic, epigenetic, and post-transcriptional alterations leave various targeted therapies ineffective, leading to a poor prognosis for high-grade glioma. Recent advances have revealed the implication of dysregulated alternative splicing (AS) events in glioma development. AS is a process that produces, from a single genomic sequence, several mature messenger RNAs. Splicing of pre-messenger RNAs concerns at least 95% of transcripts and constitutes an important mechanism in gene expression regulation. Dysregulation of this process, through variations in spliceosome components, aberrant splicing factors and RNA-binding protein activity, disproportionate regulation of non-coding RNAs, and abnormal mRNA methylation, can contribute to the disruption of AS. Such disruptions are usually associated with the development of several cancers, including glioma. Consequently, AS constitutes a key regulatory mechanism that could serve as a target for future therapies. In this review, we explore how AS events, spliceosome components, and their regulatory mechanisms play a critical role in glioma development, highlighting their potential as targets for innovative therapeutic strategies against this challenging cancer.Keywords
This publication has 99 references indexed in Scilit:
- PTBP1-mediated repression of neuron-specific CDC42 splicing constitutes a genomic alteration-independent, developmentally conserved vulnerability in IDH-wildtype glioblastomaFunctional & Integrative Genomics, 2024
- Insights into established and emerging roles of SR protein family in plants and animalsWIREs RNA, 2022
- Identification of Prognostic Signatures of Alternative Splicing in GliomaJournal of Molecular Neuroscience, 2020
- Neurochemical regulation of the expression and function of glial fibrillary acidic protein in astrocytesGlia, 2019
- A novel antisense oligonucleotide anchored on the intronic splicing enhancer of hTERT pre-mRNA inhibits telomerase activity and induces apoptosis in glioma cellsJournal of Neuro-Oncology, 2019
- Effects of hnRNP A2/B1 Knockdown on Inhibition of Glioblastoma Cell Invasion, Growth and SurvivalMolecular Neurobiology, 2015
- Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitroJournal of Neuro-Oncology, 2014
- Structural diversity and differential expression of novel human intersectin 1 isoformsMolecular Biology Reports, 2009
- Neuronal distribution of EHSH1/intersectin: Molecular linker between clathrin‐mediated endocytosis and signaling pathwaysJournal of Neuroscience Research, 2002
- Two Isoforms of a Human Intersectin (ITSN) Protein Are Produced by Brain-Specific Alternative Splicing in a Stop CodonGenomics, 1998